InvestorsHub Logo
Followers 230
Posts 21493
Boards Moderated 2
Alias Born 08/03/2006

Re: bryan2464 post# 3944

Friday, 08/19/2016 5:14:50 AM

Friday, August 19, 2016 5:14:50 AM

Post# of 10346
Stickied. Thank you Bryan. Pretty much on track with my thinking and I hadn't even listened to that until now. Getting the full data and presenting in a peer reviewed journal will be excellent. I was thinking they would be firmly on track to file for the CE mark by EOY but he left that open for possibly going into early next. That's fine. As he said, best to have every bit fully documented and protected. I liked how he explained that it would take 10 to 12 weeks or more for full data, many don't think about this and get over anxious. Not just on this one but many other bio's as well.

These puppies take time. Getting the pipeline expanded is a given. May be one device, but over time expanding the pipeline for more indications brings on so much more value. A good place to park for a long in my equity account to get to that 1 year point. Any major dips I'll be adding. Plays like this aren't for everyone. Start ups take time. The best part is? This is a medical device, NOT a drug. That cuts the years way back to being able to market. This is very cool.

My earlier post...


BooDog Thursday, 08/18/16 03:01:11 PM
Re: DFRAI post# 3941
Post # of 3950

We've got some time. There's a few steps that need to be accomplished like trial designs and other things. Getting the CE mark to me is just a fundamental improvement. Moving along after that should help but Arch needs to infiltrate for further EU trials. And get into a US trial. A lot to do. Months for the next catalyst imo. Looking forward to December for now. Getting a solid line of credit with good terms should be a priority.

Imo



Like I said, I hadn't listened to the pod cast yet but I was pretty much on track. Best to everyone.

"Perfection is not attainable, but if we chase perfection we can catch
excellence." Vince Lombardi
Do your research! Play the TA. All posts are my opinion.